SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of FDA-approved wound care products, has announced a live conference call scheduled for August 13, 2024, at 8:30 AM (ET) to present their Q2 2024 financial results. Investors can access the call via toll-free (1-800-579-2543) or international (1-785-424-1789) numbers using the Conference ID: SANUWAVE. Alternatively, instant telephone access is available through a provided link.
Conference materials will be accessible on the company's website. A replay of the call will be available until September 3, 2024, using specific replay access numbers and ID. This event provides an opportunity for stakeholders to gain insights into SANUWAVE's recent financial performance and future outlook.
SANUWAVE Health, Inc. (OTCQB: SNWV), un fornitore leader di prodotti per la cura delle ferite approvati dalla FDA, ha annunciato una conferenza telefonica in diretta programmata per il 13 agosto 2024, alle 8:30 AM (ET) per presentare i suoi risultati finanziari del Q2 2024. Gli investitori possono accedere alla chiamata tramite numero verde (1-800-579-2543) o numeri internazionali (1-785-424-1789) utilizzando l'ID Conferenza: SANUWAVE. In alternativa, è disponibile un accesso telefonico istantaneo attraverso un link fornito.
I materiali della conferenza saranno accessibili sul sito web della società. Una registrazione della chiamata sarà disponibile fino al 3 settembre 2024, utilizzando numeri specifici per il replay e l'ID. Questo evento offre un'opportunità agli azionisti per ottenere informazioni sulle recenti performance finanziarie di SANUWAVE e le prospettive future.
SANUWAVE Health, Inc. (OTCQB: SNWV), un proveedor líder de productos para el cuidado de heridas aprobados por la FDA, ha anunciado una conferencia telefónica en vivo programada para el 13 de agosto de 2024, a las 8:30 AM (ET) para presentar sus resultados financieros del Q2 2024. Los inversores pueden acceder a la llamada a través de un número gratuito (1-800-579-2543) o números internacionales (1-785-424-1789) utilizando el ID de Conferencia: SANUWAVE. Alternativamente, hay disponible acceso telefónico instantáneo a través de un enlace proporcionado.
Los materiales de la conferencia estarán disponibles en el sitio web de la empresa. Una repetición de la llamada estará disponible hasta el 3 de septiembre de 2024, utilizando números específicos de acceso a la repetición e ID. Este evento proporciona una oportunidad para que las partes interesadas obtengan información sobre el rendimiento financiero reciente de SANUWAVE y sus perspectivas futuras.
SANUWAVE 헬스 주식회사 (OTCQB: SNWV), FDA 승인을 받은 상처 관리 제품의 선도 제공업체는 2024년 8월 13일 오전 8시 30분 (동부 표준시)에 2024년 2분기 재무 결과를 발표하기 위한 라이브 컨퍼런스 콜을 예정했다고 발표했습니다. 투자자는 무료 전화 (1-800-579-2543) 또는 국제전화 (1-785-424-1789)로 컨퍼런스 ID: SANUWAVE를 사용해 통화에 접속할 수 있습니다. 대안으로 제공된 링크를 통해 즉시 전화로 접속할 수 있습니다.
컨퍼런스 자료는 회사 웹사이트에서 확인할 수 있습니다. 이 통화의 재생은 2024년 9월 3일까지 특정 재생 접근 번호와 ID를 사용해 이용할 수 있습니다. 이 이벤트는 이해관계자들이 SANUWAVE의 최근 재무 성과와 미래 전망에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
SANUWAVE Health, Inc. (OTCQB: SNWV), un fournisseur de premier plan de produits de soins des plaies approuvés par la FDA, a annoncé une conférence téléphonique en direct prévue pour le 13 août 2024 à 8h30 (ET) pour présenter ses résultats financiers du 2ème trimestre 2024. Les investisseurs peuvent accéder à l'appel via un numéro gratuit (1-800-579-2543) ou des numéros internationaux (1-785-424-1789) en utilisant l'ID de conférence : SANUWAVE. Alternativement, un accès téléphonique instantané est disponible via un lien fourni.
Les documents de la conférence seront accessibles sur le site Web de l'entreprise. Un enregistrement de l'appel sera disponible jusqu'au 3 septembre 2024, en utilisant des numéros et un ID d'accès au replay spécifiques. Cet événement offre l'opportunité aux parties prenantes d'obtenir des informations sur la récente performance financière de SANUWAVE et ses perspectives d'avenir.
SANUWAVE Health, Inc. (OTCQB: SNWV), ein führender Anbieter von von der FDA genehmigten Wundpflegeprodukten, hat eine Live-Konferenzschaltung für den 13. August 2024 um 8:30 Uhr (ET) angekündigt, um ihre finanziellen Ergebnisse für das 2. Quartal 2024 zu präsentieren. Investoren haben die Möglichkeit, über die gebührenfreie Nummer (1-800-579-2543) oder internationale Nummern (1-785-424-1789) mit der Konferenz-ID: SANUWAVE auf den Anruf zuzugreifen. Alternativ ist der sofortige Telefonzugang über einen bereitgestellten Link verfügbar.
Die Konferenzmaterialien sind auf der Unternehmenswebsite verfügbar. Eine Wiederholung des Anrufes ist bis zum 3. September 2024 mit spezifischen Wiederholungszugangszahlen und ID erhältlich. Diese Veranstaltung bietet den Interessenvertretern die Möglichkeit, Einblicke in die jüngste finanzielle Leistung von SANUWAVE und die zukünftige Perspektive zu gewinnen.
- SANUWAVE is proactively communicating with investors by hosting a conference call to discuss Q2 2024 financial results
- The company is providing multiple access options for the call, including toll-free and international numbers, as well as an instant access link
- A replay of the call will be available for an extended period, allowing investors to review the information at their convenience
- None.
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, August 13, 2024, at 8:30 AM (ET) to present the Q2 2024 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-579-2543
Toll/International: 1-785-424-1789
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event.
https://viavid.webcasts.com/starthere.jsp?ei=1684060&tp_key=35ff7216a3
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through September 3, 2024:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11156749
About SANUWAVE
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with supply chain and production constraints, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
investors@sanuwave.com
FAQ
When will SANUWAVE Health (SNWV) host its Q2 2024 financial results conference call?
How can investors access SANUWAVE's (SNWV) Q2 2024 financial results conference call?
Until what date will the replay of SANUWAVE's (SNWV) Q2 2024 financial results call be available?
Where can investors find materials for SANUWAVE's (SNWV) Q2 2024 financial results conference call?
